Understanding the Blueprint

This application translates a complex report on neurogenetics, disability claims, and regulatory standards into an interactive experience. Explore the connections between genetic variations (SNPs), their functional impacts, and their relevance in legal and policy contexts.

The Science of SNPs

Single Nucleotide Polymorphisms (SNPs) are the most common type of genetic variation among people. Each SNP represents a difference in a single DNA building block, called a nucleotide. While many SNPs have no effect on health, some can help predict an individual's risk of developing particular diseases and their response to certain drugs. This application explores specific SNPs (identified by 'rs' numbers) and their association with neurocognitive and immunological conditions, emphasizing that these links represent a *predisposition* or *increased risk* rather than a definitive diagnosis.

The Power of Visualization

Complex scientific and regulatory information can be difficult to understand through text alone. This interactive tool uses established data visualization principles to make these topics more accessible. By organizing information into thematic cards, filterable tables, and timelines, we can reveal patterns and relationships that might otherwise be hidden. The goal is to present data with clarity and accuracy, allowing you to explore the material at your own pace and draw your own insights.

Clinical & Scientific Findings

ADHD Findings

ADHD is linked to variations in genes affecting dopamine metabolism and synaptic efficiency, leading to challenges in attention and executive function.

  • rs4680 (COMT): Associated with decreased dopamine metabolism, impacting processing speed and concentration.
  • rs1800497 (DRD2): Linked to reduced D2 receptor density, contributing to executive dysfunction.
  • rs28364072 (SNAP-25): Affects synaptic efficiency and neurotransmitter release, contributing to hyperkinetic behavior.
  • Underlying Mechanism: Research points to a hypoactive dopamine system, which helps explain the effectiveness of stimulant medications that boost dopamine levels.

HIV Findings

Genetic factors influence immune response to HIV, affecting T-cell function and susceptibility to infection at mucosal surfaces.

  • rs2097629 (CD4): As CD4 T-cells are the primary target for HIV, variations in this gene are critical to disease progression and immune depletion.
  • rs602662 (FUT2): Determines "secretor phenotype." Non-secretors have been associated with a reduced risk of HIV infection, likely due to altered mucosal immunity.
  • Key Takeaway: These findings highlight the intricate interplay between an individual's genetic makeup and their body's defense mechanisms against viral pathogens.

Neurocognitive Findings

Neuroplasticity and axonal growth are fundamental to cognitive health. Genetic variations can impair these processes, contributing to various disorders.

  • rs6265 (BDNF): Linked to decreased neuroplasticity, the brain's ability to adapt and form new connections, which is crucial for learning and memory.
  • rs1018381 (DTNBP1/DISC1): Associated with impaired axonal growth and cortical regulation, essential processes for normal brain development and function.
  • Clinical Relevance: Impairments in these pathways contribute to conditions like schizophrenia and dementia, which involve deficits in working memory, learning, and problem-solving.

Neurogenetic & SSA Crosswalk

Explore the detailed relationship between specific genetic polymorphisms (SNPs) and the Social Security Administration (SSA) disability listings. Use the filters to narrow the data by associated condition.

rsID Gene Associated Condition SSA Crosswalk

Regulatory & Procedural Timeline

Technical & Regulatory Standards Crosswalk

Regulation
Applicable Standard
Requirement Summary
ADA Title II
WCAG 2.1 AA Final Rule
DOJ rule (Apr 24, 2024) adopts WCAG 2.1 Level AA for government websites & apps. Compliance by 2026-2027.
HIPAA / GINA
Privacy Rule & Non-Discrimination
HIPAA sets national standards for protected health info. GINA (May 21, 2008) prohibits discrimination based on genetic information in health coverage and employment.
IDEA
§ 300.613 Access Rights
Addresses parental rights to inspect and review education records (e.g., IEPs) within 45 days of request (effective May 3, 2017).